Loading clinical trials...

A Pilot Trial of Dextroamphetamine for Methamphetamine Dependence | Clinical Trials | Clareo Health

COMPLETEDPhase 2NCT00630682

A Pilot Trial of Dextroamphetamine for Methamphetamine Dependence

The purpose of this study is to assess the safety and effectiveness dextroamphetamine to help methamphetamine users quit or cut down on their use. The study lasts for 9 weeks. Eligible participants wi...

Lead sponsor: California Pacific Medical Center Research Institute•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment60

Start dateSep 2006

Last updatedJun 3, 2013

Condition

Methamphetamine Addiction

Locations shown

CPMC-St. Luke's Campus-Addiction Pharmacology Research Laboratory

San Francisco, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 3, 2013Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions